ICD10 code of Fanconi Anemia and ICD9 code

The primary ICD-10 code for Fanconi anemia is D61.01 (Constitutional [pure] red blood cell aplasia), while the ICD-9 code historically used was 284.89 (Other specified anemias). Because Fanconi anemia is a complex, multisystem disorder, clinicians may also utilize additional codes to describe specific physical malformations or associated malignancies as the patient’s clinical presentation evolves.

What is the clinical significance of the ICD codes for Fanconi anemia?

In medical billing and clinical documentation, Fanconi anemia is classified under codes related to bone marrow failure. Because Fanconi anemia causes progressive bone marrow failure, physical abnormalities, and a significantly increased risk of cancer, accurate coding is essential for securing insurance coverage for specialized treatments like hematopoietic stem cell transplantation (HSCT). While D61.01 is the standard administrative identifier, Fanconi anemia patients often require secondary codes to document the specific manifestations of the disease, such as short stature, radial ray defects, or squamous cell carcinomas.

How is Fanconi anemia diagnosed and categorized?

Diagnosis of Fanconi anemia is primarily confirmed through chromosomal breakage analysis, typically utilizing peripheral blood lymphocytes exposed to DNA-damaging agents like diepoxybutane (DEB) or mitomycin C. This testing is crucial because Fanconi anemia is a genetic instability syndrome characterized by a defect in the DNA repair pathway. Once clinical suspicion is raised, genetic testing identifies mutations in one of the 23 known FANC genes. Our community at DiseaseMaps.org, which includes 125 individuals living with Fanconi anemia, emphasizes that early diagnosis is vital for monitoring the progression of marrow failure and cancer surveillance.

What are the key clinical features of Fanconi anemia?

Fanconi anemia is a heterogeneous disorder, meaning the severity and symptoms vary greatly between individuals. Understanding these symptoms is critical for both patient advocacy and clinical care:

• Bone Marrow Failure: The most common feature, typically presenting between ages 5 and 10, leading to pancytopenia (low red blood cells, white blood cells, and platelets).


• Physical Malformations: Approximately 75% of individuals with Fanconi anemia exhibit physical anomalies, most commonly thumb or radius abnormalities, microcephaly, and skin pigmentation changes (café-au-lait spots).


• Cancer Predisposition: Patients have a markedly higher risk of developing acute myeloid leukemia (AML) and solid tumors, particularly in the head, neck, and gynecological regions.


• Developmental Delays: Many children may experience short stature and endocrine issues that require specialized pediatric endocrinology intervention.

Is Fanconi anemia hereditary?

Yes, Fanconi anemia is a genetic condition. It is most commonly inherited in an autosomal recessive pattern, meaning an individual must inherit a pathogenic variant in the same FANC gene from both parents. In these cases, each sibling of an affected individual has a 25% chance of being affected. One subtype, FANCB, is X-linked, and another, FANCR (RAD51), is associated with autosomal dominant inheritance. Genetic counseling is highly recommended for families to understand the inheritance pattern and recurrence risks specific to their genetic mutation.

Next steps

• Consult with a hematologist-oncologist specializing in bone marrow failure syndromes.


• Connect with the 125 members of the Fanconi anemia community on DiseaseMaps.org to share experiences and find peer support.


• Register with the Fanconi Anemia Research Fund (FARF) for access to clinical trial information and patient registry resources.


• Coordinate with a genetic counselor to discuss family planning and cascade testing for relatives.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• Orphanet: Fanconi Anemia (ORPHA:74)


• NIH Genetic and Rare Diseases (GARD) Information Center: Fanconi Anemia


• OMIM (Online Mendelian Inheritance in Man): Fanconi Anemia (Entry #227650)


• Fanconi Anemia Research Fund (FARF): Clinical Guidelines and Resources